[New, in Austria registered specialty drugs. Neupogen (G-CSF)].
出版信息
Wien Klin Wochenschr. 1991;103(21):661-6.
PMID:1722934
Abstract
摘要
相似文献
1
[New, in Austria registered specialty drugs. Neupogen (G-CSF)].[新的，在奥地利注册的专科药物。优保津（粒细胞集落刺激因子）]
Wien Klin Wochenschr. 1991;103(21):661-6.
2
[Rational therapy with G-CSF and GM-CSF].
Med Klin (Munich). 1994 Aug 15;89(8):429-41.
3
[Integration of G-CSF in prevention and therapy of neutropenic fever].[粒细胞集落刺激因子在中性粒细胞减少性发热预防和治疗中的应用]
Med Klin (Munich). 1996 Feb 15;91(2):82-8.
4
[Recombinant human granulocyte colony-stimulating factor (G-CSF)].[重组人粒细胞集落刺激因子（G-CSF）]
Gan To Kagaku Ryoho. 1993 Mar;20(4):541-9.
5
[G-CSF in patients with lupus-associated neutropenia and infections].[粒细胞集落刺激因子用于狼疮相关中性粒细胞减少症及感染患者]
Z Rheumatol. 1996 May-Jun;55(3):174-9.
6
7
[New specialty drugs admitted in Austria and new knowledge regarding drugs already in longer use. Leucomax-Aesca dry injection ampule with solution. Leucomax-Sandoz dry injection ampule with solution].[奥地利批准的新专科药物以及关于已长期使用药物的新知识。Leucomax - Aesca 溶液型冻干注射剂安瓿。Leucomax - 山德士溶液型冻干注射剂安瓿]
Wien Klin Wochenschr. 1993;105(10):299-305.
8
Granulocyte colony-stimulating factor: a new approach in the treatment of childhood neutropenia.
J Med Assoc Ga. 1992 Aug;81(8):437-41.
9
Correction of neutropenia following treatment with granulocyte colony-stimulating factor results in a decreased frequency of infections in Shwachman's syndrome.使用粒细胞集落刺激因子治疗后中性粒细胞减少症的纠正，可降低施瓦茨曼综合征患者的感染频率。
Neth J Med. 1996 Mar;48(3):92-5. doi: 10.1016/0300-2977(95)00049-6.
10
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.粒细胞集落刺激因子和粒细胞-巨噬细胞集落刺激因子：比较及在非中性粒细胞减少患者感染治疗中的应用潜力
J Infect Dis. 1999 Mar;179 Suppl 2:S342-52. doi: 10.1086/513857.
Zotero 插件